Prolintane
From Wikipedia, the free encyclopedia
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
1-(1-Benzylbutyl)pyrrolidine
|
|
| Clinical data | |
| Routes of administration |
oral, intranasal, rectal |
| Identifiers | |
| CAS Number | 493-92-5  |
| ATC code | N06BX14 |
| PubChem | CID 14592 |
| ChemSpider | 13930  |
| UNII | EM4YZW677H |
| Chemical data | |
| Formula | C15H23N |
| Molar mass | 217.35 g/mol |
|
|
|
|
| (what is this?) (verify) |
Prolintane (Catovit, Promotil, Villescon) is a stimulant[1] and norepinephrine-dopamine reuptake inhibitor developed in the 1950s.[2] It is closely related in chemical structure to other drugs such as pyrovalerone, MDPV, and propylhexedrine and it has a similar mechanism of action.[3] Many cases of prolintane abuse have been reported.[4]
See also[edit]
- α-PVP (β-ketone-prolintane, prolintanone)
- Methylenedioxypyrovalerone (MDPV)
- Pyrovalerone (Centroton, Thymergix)
References[edit]
- ^ Hollister, L. E.; Gillespie, H. K. (1970). "A new stimulant, prolintane hydrochloride, compared with dextroamphetamine in fatigued volunteers". The Journal of Clinical Pharmacology 10 (2): 103–109. doi:10.1177/009127007001000205. PMID 4392006.
- ^ GB Patent 807835
- ^ Nicholson, A. N.; Stone, B. M.; Jones, M. M. (1980). "Wakefullness and reduced rapid eye movement sleep: Studies with prolintane and pemoline". British Journal of Clinical Pharmacology 10 (5): 465–472. doi:10.1111/j.1365-2125.1980.tb01790.x. PMC 1430138. PMID 7437258.
- ^ Kyle, P. B.; Daley, W. P. (2007). "Domestic Abuse of the European Rave Drug Prolintane". Journal of Analytical Toxicology 31 (7): 415–418. doi:10.1093/jat/31.7.415. PMID 17725890.
|
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
